Europska Unija - norveški - EMA (European Medicines Agency)

leo pharma a/s - tralokinumab - dermatitt, atopisk - andre dermatologiske preparater - adtralza is indicated for the treatment of moderate to severe atopic dermatitis in adult and adolescent patients 12 years and older who are candidates for systemic therapy.

Europska Unija - norveški - EMA (European Medicines Agency)

astrazeneca ab - anifrolumab - lupus erythematosus, systemisk - immunsuppressive - saphnelo is indicated as an add-on therapy for the treatment of adult patients with moderate to severe, active autoantibody-positive systemic lupus erythematosus (sle), despite standard therapy.

Europska Unija - norveški - EMA (European Medicines Agency)

serb sa - amifampridine phosphate - lambert-eaton myasthenic syndrome; paraneoplastic syndromes, nervous system; nervous system neoplasms; paraneoplastic syndromes; nervous system diseases; autoimmune diseases of the nervous system; neurodegenerative diseases; neuromuscular diseases; neuromuscular junction diseases; immune system diseases; autoimmune diseases; autoimmune diseases of the nervous system; cancer; neoplasms - andre nervesystemet narkotika - symptomatisk behandling av lambert-eaton myasthenisk syndrom (lems) hos voksne.

Norveška - norveški - Statens legemiddelverk

paranova as - takrolimusmonohydrat - depottablett - 4 mg

Norveška - norveški - Statens legemiddelverk

novartis norge (2) - ciklosporin - kapsel, myk - 25 mg

Norveška - norveški - Statens legemiddelverk

novartis norge (2) - ciklosporin - kapsel, myk - 50 mg

Norveška - norveški - Statens legemiddelverk

novartis norge (2) - ciklosporin - kapsel, myk - 100 mg

Norveška - norveški - Statens legemiddelverk

novartis norge (2) - ciklosporin - mikstur, oppløsning - 100 mg/ ml

Norveška - norveški - Statens legemiddelverk

sandoz a/s - valaciklovirhydroklorid - tablett, filmdrasjert - 500 mg

Norveška - norveški - Statens legemiddelverk

sandoz a/s - valaciklovirhydroklorid - tablett, filmdrasjert - 250 mg